Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarkers for Clinical Trials of Drugs Active Against Latent TB
NCT00293228Phase 4Completed
- Sponsor
- Instituto Nacional de Salud Pública
- Start
- Feb 2007
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of isoniazid in Tuberculosis (TB) (4 arms), sponsored by Instituto Nacional de Salud Pública. Primary endpoint: Frequency of Mtb antigen-specific IFNγ-producing T cells at 9 months. Started Feb 2007; status: completed.
02
Drugs
isoniazid
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT00293228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00293228.